Artwork

Content provided by Luke Johnson. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Luke Johnson or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

141. Ruxolitinib vs triamcinolone - Topical tofacitinib for LPP/FFA - Locus of control in AD - Low-dose naltrexone for LPP/FFA - Alternative/complementary treatments for HSV

59:20
 
Share
 

Manage episode 442761844 series 3192412
Content provided by Luke Johnson. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Luke Johnson or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Ruxolitinib vs triamcinolone -

Topical tofacitinib for LPP/FFA -

Locus of control in AD -

Low-dose naltrexone for LPP/FFA -

Alternative/complementary treatments for HSV -

Want to donate to the cause? Do so here!

Donate to the podcast: uofuhealth.org/dermasphere

Check out our video content on YouTube:

www.youtube.com/@dermaspherepodcast

and VuMedi!: www.vumedi.com/channel/dermasphere/

The University of Utah's Dermatology

ECHO: ⁠physicians.utah.edu/echo/dermatology-primarycare -

⁠ Connect with us!

- Web: ⁠dermaspherepodcast.com/⁠ - Twitter: @DermaspherePC

- Instagram: dermaspherepodcast

- Facebook: www.facebook.com/DermaspherePodcast/

- Check out Luke and Michelle’s other podcast,

SkinCast! ⁠healthcare.utah.edu/dermatology/skincast/⁠ Luke and Michelle report no significant conflicts of interest… BUT check out our

friends at:

- ⁠Kikoxp.com ⁠(a social platform for doctors to share knowledge)

- ⁠www.levelex.com/games/top-derm⁠ (A free dermatology game to learn

more dermatology!

  continue reading

168 episodes

Artwork
iconShare
 
Manage episode 442761844 series 3192412
Content provided by Luke Johnson. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Luke Johnson or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Ruxolitinib vs triamcinolone -

Topical tofacitinib for LPP/FFA -

Locus of control in AD -

Low-dose naltrexone for LPP/FFA -

Alternative/complementary treatments for HSV -

Want to donate to the cause? Do so here!

Donate to the podcast: uofuhealth.org/dermasphere

Check out our video content on YouTube:

www.youtube.com/@dermaspherepodcast

and VuMedi!: www.vumedi.com/channel/dermasphere/

The University of Utah's Dermatology

ECHO: ⁠physicians.utah.edu/echo/dermatology-primarycare -

⁠ Connect with us!

- Web: ⁠dermaspherepodcast.com/⁠ - Twitter: @DermaspherePC

- Instagram: dermaspherepodcast

- Facebook: www.facebook.com/DermaspherePodcast/

- Check out Luke and Michelle’s other podcast,

SkinCast! ⁠healthcare.utah.edu/dermatology/skincast/⁠ Luke and Michelle report no significant conflicts of interest… BUT check out our

friends at:

- ⁠Kikoxp.com ⁠(a social platform for doctors to share knowledge)

- ⁠www.levelex.com/games/top-derm⁠ (A free dermatology game to learn

more dermatology!

  continue reading

168 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide